Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

References

• NewsomeLTKutcherMARoysterRLCoronary artery stents, Part I: Evolution of percutaneous coronary interventionAnesth Analg200810755256918633035
   PubMed Web of Science ®Google Scholar
• SharmaRKReddyHKSinghVNAspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stentingVasc Health Risk Manag2009596597219997577
   PubMedGoogle Scholar
• GasparyanAYAspirin and clopidogrel resistance: methodological challenges and opportunitiesVasc Health Risk Manag20106109101220448796
   PubMedGoogle Scholar
• FerrandisRLlauJVMugarraAPerioperative management of antiplatelet-drugs in cardiac surgeryCurr Cardiol Rev2009512513220436853
   PubMedGoogle Scholar
• SpahnDRHowellSJDelabaysAChassotPGCoronary stents and perioperative antiplatelet regimen: dilemma of bleeding and stent thrombosisBr J Anaesth20069667567716698866
   PubMed Web of Science ®Google Scholar
• RabbitsJANuttallGABrownMJCardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stentsAnesthesiology200810959660418813037
   PubMed Web of Science ®Google Scholar
• LlauJVLópez-ForteCSapenaMLFerrandisRPerioperative management of antiplatelet agents in noncardiac surgeryEur J Anaesthesiol20092618118719244686
   PubMed Web of Science ®Google Scholar
• ChassotPGDelabaysASpanhDRPerioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarctionBr J Anaesth20079931632817650517
   PubMed Web of Science ®Google Scholar
• PatronoCBaigentCHirshJRothGAntiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)Chest2008133Suppl 6199S233S18574266
   PubMed Web of Science ®Google Scholar
• AngiolilloDFerreiroJLPlatelet adenosin diphosphate P2Y12 receptor antagonism: benefit and limitations of current treatment strategies and future directionsRev Esp Cardiol201063607620089227
   PubMed Web of Science ®Google Scholar
• VaneJRBottingRMThe mechanism of action of aspirinThromb Res200311025525814592543
   PubMed Web of Science ®Google Scholar
• CoxDMareeAODooleyMConroyRByrneMFFitzgeraldDJEffect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteersStroke2006372153215816794200
   PubMed Web of Science ®Google Scholar
• JimenezAHStubbsMEToflerGHWintherKWilliamsGHMullerJERapidity and duration of platelet suppression by enteric-coated aspirin in healthy young menAm J Cardiol1992692582621731469
   PubMed Web of Science ®Google Scholar
• DienerHCCunhaLForbesCSiveniusJSmetsPLowenthalAEuropean Stroke Prevention Study, Part II: Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeJ Neurol Sci19961431138981292
   PubMed Web of Science ®Google Scholar
• International Stroke Trial Collaborative GroupThe International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic strokeLancet19973499065156915819174558
   PubMed Web of Science ®Google Scholar
• ISIS-2 Collaborative GroupRandomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2Lancet1988286073493602899772
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists CollaborationCollaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar
• LandolfiRMarchioliRKuttiJEfficacy and safety of low-dose aspirin in polycythemia veraN Engl J Med200435011412414711910
   PubMed Web of Science ®Google Scholar
• LorenzRLSchackyCVWeberMImproved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formationLancet198418389126112646144975
   PubMed Web of Science ®Google Scholar
• Juul-MöllerSEdvardssonNJahnmatzBRosénASørensenSOmblusRDouble-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisLancet19923408833142114251360557
   PubMed Web of Science ®Google Scholar
• GasparyanAYWatsonTLipGYThe role of aspirin in cardiovascular prevention: implications of aspirin resistanceJ Am Coll Cardiol2008511829184318466797
   PubMed Web of Science ®Google Scholar
• BonviniRFRenyJLMachFAcute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistanceCurr Vasc Pharmacol2009719820819356003
   PubMed Web of Science ®Google Scholar
• GachetCThe platelet P2 receptors as molecular targets for old and new antiplatelet drugsPharmacol Ther200510818019215955565
   PubMed Web of Science ®Google Scholar
• BoeynaemsJMvan GiezenHSaviPHerbertJMP2Y12 receptor antagonists in thrombosisCurr Opin Investig Drugs20056275282
   PubMedGoogle Scholar
• CAPRIE Steering CommitteeA randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)Lancet19963489038132913398918275
   PubMed Web of Science ®Google Scholar
• SudlowCLMasonGMauriceJBWedderburnCJHankeyGJThienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patientsCochrane Database Syst Rev20094CD00124619821273
   PubMed Web of Science ®Google Scholar
• MehtaSRYusufSClopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study InvestigatorsThe Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular diseaseEur Heart J2000212033204111102254
   PubMed Web of Science ®Google Scholar
• BowryADBrookhartMAChoudhryNKMeta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular eventsAm J Cardiol200810196096618359315
   PubMed Web of Science ®Google Scholar
• De LucaGCassettiEMarinoPImpact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trialsJ Thromb Thrombolysis20092736537818498003
   PubMed Web of Science ®Google Scholar
• AntmanEMAnbeDTArmstrongPWACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionJ Am Coll Cardiol20044467171915358045
   PubMedGoogle Scholar
• SilberSAlbertssonPAvilésFFGuidelines for percutaneous coronary interventionsEur Heart J20052680484715769784
   PubMed Web of Science ®Google Scholar
• DugganSTKeatingGMPrasugrel: a review of its use in patients with acute coronary syndromes undergoing percutaneous coronary interventionDrugs2009691707172619678718
   PubMed Web of Science ®Google Scholar
• MarzotFPengoVPrasugrel for the treatment of patients with acute coronary syndromeVasc Health Risk Manag2009532132419436677
   PubMedGoogle Scholar
• MotovskaZWidimskyPImproving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrelVasc Health Riak Manag20095475481
   PubMedGoogle Scholar
• NorgardNBAbu-FadelMComparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary interventionVasc Health Riak Manag20095873882
   PubMedGoogle Scholar
• SilvaMADonovanJLGandhiPJPlatelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or bothVasc Health Risk Manag20062394817319468
   PubMedGoogle Scholar
• TchengJEEllisSGGeorgeBSPharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyCirculation199490175717647923659
   PubMed Web of Science ®Google Scholar
• EPIC InvestigatorsUse of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplastyN Engl J Med19943309569618121459
   PubMed Web of Science ®Google Scholar
• EPILOG InvestigatorsPlatelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularizationN Engl J Med1997336168916969182212
   PubMed Web of Science ®Google Scholar
• EPISTENT InvestigatorsRandomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeLancet1998352912287929672272
   PubMed Web of Science ®Google Scholar
• TopolEJLincoffAMKereiakesDJMulti-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularizationAm J Med20021131612106616
   PubMed Web of Science ®Google Scholar
• BisharaAIHagmeyerKOAcute profound thrombocytopenia following abciximab therapyAnn Pharmacother20003492493010928405
   PubMed Web of Science ®Google Scholar
• BarrettJSMurphyGPeerlinckKPharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy menClin Pharmacol Ther1994563773887955799
   PubMed Web of Science ®Google Scholar
• Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study InvestigatorsA comparison of aspirin plus tirofiban with aspirin plus heparin for unstable anginaN Engl J Med1998338149815059599104
   PubMed Web of Science ®Google Scholar
• RESTORE InvestigatorsEffects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplastyCirculation199796144514539315530
   PubMed Web of Science ®Google Scholar
• HarringtonRAKleimanNSKottke-MarchantKImmediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous interventionAm J Cardiol199576122212277503000
   PubMed Web of Science ®Google Scholar
• TchengJEHarringtonRAKottke-MarchantKMulticenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary interventionCirculation199591215121577697843
   PubMed Web of Science ®Google Scholar
• PURSUIT Trial InvestigatorsInhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromesN Engl J Med19983394364439705684
   PubMed Web of Science ®Google Scholar
• MichelsonADMethods for the measurement of platelet functionAm J Cardiol2009103Suppl 320A26A
   PubMedGoogle Scholar
• ChristiaensLMacchiLMonitoring of the antiplatelet drugs effect in patients with coronary artery disease: what is the real clinical impactCurr Vasc Pharmacol2007529330117979795
   PubMed Web of Science ®Google Scholar
• GibbsNMPoint-of-care assessment of antiplatelet agents in the perioperative period: a reviewAnaesth Intensive Care20093735436919499855
   PubMed Web of Science ®Google Scholar
• Howard-AlpeGMde BonoJHudsmithLCoronary artery stents and non-cardiac surgeryBr J Anaesth20079856057417456488
   PubMed Web of Science ®Google Scholar
• CraftRMChavezJJSniderCCComparison of modified thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patientsJ Lab Clin Med200514530931515976759
   PubMed Web of Science ®Google Scholar
• LennonMJGibbsNMWeigthmanWMA comparison of Plateletworks™ and platelet aggregometry for the assessment of aspirin- related platelet dysfunction in cardiac surgical patientsJ Cardiothorac Vasc Anesth20041813614015073699
   PubMed Web of Science ®Google Scholar
• MalininASperglingMMuhlesteinBAssessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzerBlood Coagul Fibrinolysis20041529530115166914
   PubMed Web of Science ®Google Scholar
• RoyPOkabeTPinto SlottowTLCorrelates of clinical restenosis following intracoronary implantation of drug-eluting stentsAm J Cardiol200710096596917826379
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus-and paclitaxel-eluting coronary stentsN Eng J Med20073569981008
   PubMed Web of Science ®Google Scholar
• DoostzadehJClarkLNBezenekSPiersonWSoodPRSudhirKRecent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stentCoron Artery Dis201021465619952925
   PubMed Web of Science ®Google Scholar
• Pinto SlottowTLWaksmanRDrug-eluting stent safetyAm J Cardiol2007100Suppl 210M17M
   PubMedGoogle Scholar
• AwataMKotaniJUematsuMSerial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stentsCirculation200711691091617684153
   PubMed Web of Science ®Google Scholar
• SpertusJAKettelkampRVanceCPrevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registryCirculation20061132803280916769908
   PubMed Web of Science ®Google Scholar
• KingSBSmithSCHirshfeldJWJacobsAKMorrisonDAWilliamsDO2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing CommitteeCirculation200811726129518079354
   PubMedGoogle Scholar
• CohenMAntiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AH/ACC/SCAI guidelines and beyondCatheter Cardiovasc Interv20097457959719472347
   PubMed Web of Science ®Google Scholar
• CuissetTFrereCQuiliciJBenefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stentingJ Am Coll Cardiol2006481339134517010792
   PubMed Web of Science ®Google Scholar
• YongGRankinJFergusonLRandomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non- ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary Intervention in Acute Coronary Lesions (PRACTICAL) TrialAm Heart J200915760.e160.e919081397
   PubMed Web of Science ®Google Scholar
• MehtaSRYusufSPetersRJEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyLancet2001358928152753311520521
   PubMed Web of Science ®Google Scholar
• BeckerRCMeadeTWBergerPBThe primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008133Suppl 6776S814S18574278
   PubMed Web of Science ®Google Scholar
• EisensteinELAnstromKJKongDFClopidogrel use and longterm clinical outcomes after drug-eluting stent implantationJAMA200729715916817148711
   PubMed Web of Science ®Google Scholar
• JenningsDLKalusJSAddition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysisJ Clin Pharmacol201050441542120081227
   PubMed Web of Science ®Google Scholar
• AlbaladejoPMarretEPiriouVSamamaCMPerioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task ForceBr J Anaesth20069758058216956897
   PubMed Web of Science ®Google Scholar
• DouketisJDBergerPBDunnASThe perioperative management of antithrombotic therapyChest2008133299S339S18574269
   PubMed Web of Science ®Google Scholar
• LecompteTHardyJFAntiplatelet agents and perioperative bleedingCan J Anesth200653S103S11216766783
   PubMed Web of Science ®Google Scholar
• BurgerWChemnitiusJMKneisslGDRückerGLow-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysisJ Intern Med200525739941415836656
   PubMed Web of Science ®Google Scholar
• HelfriedMFlorianPMünchAPremature discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoringEur J Anaesthesiol20102713814519593147
   PubMed Web of Science ®Google Scholar
• SamamaCMBastienOForestierFthe expert groupAntiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 – summary statementCan J Anesth200249S26S3512557412
   PubMed Web of Science ®Google Scholar
• SabatéSMayoralMVernettaDHernandoDBaxariasPIntraoperative blood loss and transfusion requirements for radical laparoscopic vs radical retropubic prostatectomyEur J Anaesthesiol200825Suppl 4490
   Google Scholar
• SchoutenOvan DomburgRTBaxJJNoncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac eventsJ Am Coll Cardiol20074912212417207733
   PubMed Web of Science ®Google Scholar
• FoxKAAMehtaSRPetersRBenefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) TrialCirculation20041101202120815313956
   PubMed Web of Science ®Google Scholar
• WenaweserPReyCEberliFRStent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcomeEur Heart J2005261180118715728650
   PubMed Web of Science ®Google Scholar
• IakovouISchmidtTBonizzoniEIncidence, predictors, and outcomes of thrombosis after successful implantation of drug-eluting stentsJAMA20052932126213015870416
   PubMed Web of Science ®Google Scholar
• Balaguer-MalfagónJRPomar-DomingoFVilar-HerreroJVPlanas-del ViejoAMPérez-FernándezETrombosis del stent en la era moderna: incidencia, consecuencias y factores predictores (Spanish)Rev Esp Cardiol20065984284516938235
   PubMedGoogle Scholar
• De la Torre-HernándezJMAlfonsoFHernándezFDrug- eluting stent thrombosis: results from the multicenter Spanish Registry ESTROFA (Estudio EsSpanol sobre TROmbosis de stents FArmacoactivos)J Am Coll Cardiol20085198699018325436
   PubMed Web of Science ®Google Scholar
• CaixetaALeonMBLanskyAJ5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsJ Am Coll Cardiol20095489490219712798
   PubMed Web of Science ®Google Scholar
• CutlipDEWindeckerSMehranRClinical end points in coronary stent trials: a case for standardized definitionsCirculation20071152344235117470709
   PubMed Web of Science ®Google Scholar
• CamenzindEStegPGWijnsWStent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernCirculation20071151440145517344324
   PubMed Web of Science ®Google Scholar
• GrinesCLBonowROCaseyDEPrevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stentsJ Am Coll Cardiol20074973473917291948
   PubMed Web of Science ®Google Scholar
• CarlssonJJamesSKLindbäckJOutcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteriaJ Am Coll Cardiol2009531389139819371822
   PubMed Web of Science ®Google Scholar
• KirtaneAJGuptaAIyengarSSafety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studiesCirculation20091193198320619528338
   PubMed Web of Science ®Google Scholar
• LagerqvistBCarlssonJFröbertOStent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty RegistryCirc Cardiovasc Interv2009240140820031749
   PubMed Web of Science ®Google Scholar
• PopescuWMPerioperative management of the patient with a coronary stentCurr Opin Anaesthesiol20102310911519901828
   PubMed Web of Science ®Google Scholar
• BaranKWLasalaJMCoxDAA clinical risk score for prediction of stent thrombosisAm J Cardiol200810254154518721509
   PubMed Web of Science ®Google Scholar
• van WerkumJWHeestermansAAZomerACPredictors of coronary stent thrombosis: the Dutch Stent Thrombosis RegistryJ Am Coll Cardiol2009531399140919371823
   PubMed Web of Science ®Google Scholar
• RoyPBonelloLTorgusonRTemporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantationAm J Cardiol200910380180519268735
   PubMed Web of Science ®Google Scholar
• KimuraTMorimotoTNakagawaYAntiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantationCirculation200911998799519204304
   PubMed Web of Science ®Google Scholar
• VincenziMNMeislitzerTHeitzingerBHalajMFleisherLAMetzlerHCoronary artery stenting and non-cardiac surgery. A prospective outcome studyBr J Anaesth20069668669316670113
   PubMed Web of Science ®Google Scholar
• NewsomeLTWellerRSGerancherJCKutcherMARoysterRLCoronary artery stents, Part II: Perioperative considerations and managementAnesth Analg200810757059018633036
   PubMed Web of Science ®Google Scholar
• SierraPTormosPUnzuetaMCSabatéMMonsalveCSabatéSManejo perioperatorio de la antiagregación en pacientes portadores de stent coronario (Spanish)Rev Esp Anestesiol Reanim200855Suppl 111418333379
   PubMedGoogle Scholar
• LehotJStaatPFfrenchPVichovaZCannessonMCoronary stents and anaesthesiaAnn Fr Anesth Reanim200726978479017692497
   PubMedGoogle Scholar
• KingSBSmithSCHirshfeldJW2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelinesJ Am Coll Cardiol20085117220918191745
   PubMed Web of Science ®Google Scholar
• PoldermansDBaxJJBoersmaEGuidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgeryEur Heart J2009302769281219713421
   PubMed Web of Science ®Google Scholar
• BroadLLeeTConroyMSuccessful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgeryBr J Anaesth200798192217124186
   PubMed Web of Science ®Google Scholar
• BigalkeBSeizerPGeislerTLindemannSGawazMMayAEPerioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgeryClin Res Cardiol200998533533919283333
   PubMed Web of Science ®Google Scholar
• EisenbergMJRichardPRLibersanDFilionKBSafety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stentsCirculation20091191634164219289638
   PubMed Web of Science ®Google Scholar
• DespotisGEbyCLublinDMA review of transfusion risks and optimal management of perioperative bleeding with cardiac surgeryTransfusion2008482S30S18302579
   PubMed Web of Science ®Google Scholar
• LauritzenBTranholmMEzbanMrFVIIa and a new enhanced rFVIIa 10analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic ratsJ Thromb Haemost2009765165719175492
   PubMed Web of Science ®Google Scholar
• BornemannHPrüllerFMetzlerHThe patient with coronary stents and antiplatelet agents: what to do and how to deal?Eur J Anaesthesiol 201027540641010.1097/EJA.0b013e328225b28420009935
   PubMed Web of Science ®Google Scholar
• VilahurGChoiBGZafarMUNormalization of platelet reactivity in clopidogrel-treated subjectsJ Thromb Haemost20075829017239165
   PubMed Web of Science ®Google Scholar
• SavonitoSD’UrbanoMCaraccioloMUrgent surgery in patients with recently implanted coronary drug-eluting stent: a phase II study of “bridging” antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrelBr J Anaesth2010104328529120047898
   PubMed Web of Science ®Google Scholar